Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.
Open Access
- 1 November 1995
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 96 (5) , 2404-2412
- https://doi.org/10.1172/jci118297
Abstract
Immunoglobulins regulate the complement system by activating complement on foreign surfaces and diverting reactive complement proteins away from autologous cell surfaces. Based on this model, we explored the ability of Ig to balance complement activation versus control in a pig-to-primate cardiac xenotransplantation model in which the binding of xenoreactive antibodies of the recipient to graft blood vessels and the activation of complement cause hyperacute rejection. Human IgG added to human serum caused a dose-dependent decrease in deposition of iC3b, cytotoxicity, and heparan sulfate release when the serum was incubated with porcine endothelial cells. This decrease was not caused by alteration in antibody binding or consumption of complement but presumably reflected decreased formation of C3 convertase on the endothelial cells. Infusion of purified human IgG into nonhuman primates prevented hyperacute rejection of porcine hearts transplanted into the primates. As expected, the transplants contained deposits of recipient Ig and C1q but not other complement components. The inhibition of complement on endothelial cell surfaces and in the xenotransplantation model supports the idea that IgG regulates the classical complement pathway and supports therapeutic use of that agent in humoral-mediated disease.Keywords
This publication has 41 references indexed in Scilit:
- Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive natural antibodies.The Journal of Immunology, 1995
- Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injuryNature Medicine, 1995
- The Classical Complement Pathway: Activation and Regulation of the First Complement ComponentPublished by Elsevier ,1985
- C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.The Journal of Experimental Medicine, 1984
- A unique natural human IgG antibody with anti-alpha-galactosyl specificity.The Journal of Experimental Medicine, 1984
- The role of antibody in the activation of the alternative complement pathwaySpringer Seminars in Immunopathology, 1983
- Immune cell populations in cutaneous delayed-type hypersensitivity.The Journal of Experimental Medicine, 1983
- Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.Journal of Clinical Investigation, 1983
- Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine.Journal of Histochemistry & Cytochemistry, 1983
- Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.The Journal of Immunology, 1982